Prospective randomized multicenter clinical trial on the use of interferon α-2a plus acitretin versus interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II

Blood

Volumn 92, Issue 10, 1998, Pages 3578-3581

  Stadler, R ^a   Otte, H G ^b   Luger, T ^b   Henz, B M ^b   Kuhl P ^b   Zwingers, T ^b   Sterry, W ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; METHOXSALEN; RECOMBINANT ALPHA2A INTERFERON; RETINOID;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRY SKIN; ERYTHEMA; FEMALE; FLU LIKE SYNDROME; HAIR LOSS; HELPER CELL; HUMAN; IMPOTENCE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; RANDOMIZED CONTROLLED TRIAL; SKIN LYMPHOMA; SUBCUTANEOUS DRUG ADMINISTRATION; T CELL LYMPHOMA;

ACITRETIN; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERFERON ALFA-2A; LYMPH NODES; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PUVA THERAPY; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0032533917     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Edelson RL: Cutaneous T-cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol 2:89, 1980
2. Bunn PA Jr, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeggren J, Shenwin S, Oldham R: Recombinant leucocyte A Interferon: An active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101:484, 1984
3. Bunn PA Jr, Hoffman SJ, Norris D, Golitz E, Aeling JL: Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome). Ann Intern Med 121:592, 1994
4. Kuzel TM, Roenigk HH Jr, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, Rosen ST: Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome. J Clin Oncol 13:257, 1995
5. Otte HG, Merges A, Stadler R: Kombinationstherapie mit Interferon alfa 2a und PUVA bei kutanen T-Zell-Lymphomen. Hautarzt 43:695, 1992
6. Dreno B, Claudy A, Meynadier J, Verret JL, Souteyrand P, Ortonne JP, Kalis B, Godefroy WY, Beerblock R, Thill L: The treatment of 45 patients with cutaneous T-cell lymphoma with low dose interferon-alfa-2a and etretinate. Br J Dermatol 125:456, 1991
7. Thestrup-Pedersen K, Hammer R, Kaltoft K, Sogard H, Zachariae H: Treatment of mycosis fungoides with recombinant interferon-alpha-2a alone and in combination with etretinate. Br J Dermatol 118:811, 1988
8. Altomare GF, Capella GI, Pigatto PD, Finzi AF: Intramuscular low dose alpha-2b interferon and etretinate for treatment of mycosis fungoides. Int J Dermatol 32:138, 1993
9. Stavhaneas N, Katsambas A, Vareltzides A, Stavropoulos P, Polydorou D, Zika P, Stratigos J: Treatment of mycosis fungoides with recombinant alpha 2b interferon in combination with etretinate. J Invest Dermatol 93:580, 1989
10. Braathen LS, McFadden N: Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alfa-2a. J Dermatol Treat 1:29, 1989
11. Bunn PA Jr, Lamberg SI: Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725, 1979
12. Sterry W. Therapie der kutanen malignen Lymphome. Dtsch Med Wochenschr 113:221, 1988
13. Tanew A, Hönigsmann H: Ultraviolet B and psoralen plus UVA phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 4:38, 1997
14. Rajan GP, Seifert B, Prümmer O, Joller-Jemelka HI, Burg G, Dummer R: Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Arch Dermatol Res 288:543, 1996